The early use of Antibiotics in at Risk CHildren with InfluEnza Chief Investigator: Dr Kay Wang Senior Trial.

Slides:



Advertisements
Similar presentations
Combs Ford Surgery Patient Information Screen October 2013.
Advertisements

Proper Use of Antibiotics June Proper Use of Antibiotics What are antibiotics? Are there any risks for the use of antibiotics? How to use antibiotics.
Tuberculosis in Children: Prevention Module 10C - March 2010.
Launch Event – 6 th November 2014 Trial Information and Design Isabel Rubie – Trial Manager The NAtional Trial of Tonsillectomy IN Adults: a clinical and.
Regional Fertility Centre Joan Couhig Administration & Quality Co-ordinator Saturday 27 September 2014 Joan Couhig Administration & Quality Co-ordinator.
Dr. Christina Reith CTSU, University of Oxford ASCEND: A Study of Cardiovascular Events iN Diabetes.
Maximizing Recruitment in ACST-2. Recruitment to Date Clinical trials require VERY large numbers of patients, because they study MODERATE effects… … therefore.
Trial Procedures and Forms
The purpose of this pilot study was to determine the feasibility of conducting a prospective cohort study with sufficient follow-up in a population of.
The early use of Antibiotics in at Risk CHildren with InfluEnza Chief Investigator: Dr Kay Wang Senior Trial.
The early use of Antibiotics in at Risk CHildren with InfluEnza Chief Investigator: Dr Kay Wang Senior Trial.
Seasonal and H1N1 Flu Guidance on helping Child Care and Early Childhood Programs respond to Influenza Season September 17, 2009 Presented by: Leona Davis.
Combs Ford Surgery Patient Information Screen November 2013.
Alastair Hay, Consultant Senior Lecturer in Primary Health Care The TARGET Programme: strengths, weaknesses, opportunities and lessons learned (so far).
EAE Training EAE Reporting and Assessment Overview DAIDS Regional Training Event, Regulatory Compliance Center Kampala, Uganda, September 2009 DAIDS Regional.
Mette Krag, MD, coordinating investigator
Teenage Vaccinations Flu vaccination in schools September 2013.
The early use of Antibiotics in at Risk CHildren with InfluEnza Eligibility assessment and recruitment tips
The early use of Antibiotics in at Risk CHildren with InfluEnza Medical notes review
Medicines Authority 203,Level 3, Rue D’Argens, Gzira,GZR 1368 Tel: (+356) Fax: (+356) ov.mt Reporting.
The national flu immunisation programme Training for Receptionists 2015/2016.
Myths about flu and the flu vaccine
COMMUNITY PHARMACY WORKBOOK PUBLIC HEALTH DORSET
HOW TO TRAIN PATIENTS ON COMPLETING THE QUESTIONNAIRES
HOW TO SCREEN PATIENTS AND BOOK THE BASELINE VISIT APPOINTMENT?
Søren Marker Jensen, MD, coordinating investigator
What is seasonal flu? It is spread through coughs and sneezes
CACFP Day Care Home Forms
Karyn Probert NHS Gloucestershire CCG
Preparing for Flu Season
Have you been diagnosed with Gorlin Syndrome,
HOW TO ENTER EARLY WITHDRAWAL DATA
CONDUCTING THE TRIAL AT
MAINTAINING THE INVESTIGATOR’S SITE FILE
The early use of Antibiotics in at Risk CHildren with InfluEnza www
Site Initiation Meeting GP Practice
Chief Investigator: Dr Kay Wang Senior Trial Manager: Tricia Carver
The early use of Antibiotics in at Risk CHildren with InfluEnza
HOW TO ENTER BASELINE DATA
Chief Investigator: Dr Kay Wang Senior Trial Manager: Tricia Carver
DATABASE SEARCH & REVIEW GETTING STARTED GUIDE FOR EMIS WEB USERS
Electronic Repeat Dispensing (ERD)
The early use of Antibiotics in at Risk CHildren with InfluEnza
The early use of Antibiotics in at Risk CHildren with InfluEnza
Within Trial Decisions: Unblinding and Termination
Making an Appointment Last week you learned about different types of healthcare providers. To meet with them, you will need to make an appointment. Here,
HOW TO CONSENT A PATIENT?
Aiming for complete data
The early use of Antibiotics in at Risk CHildren with InfluEnza www
HEDIS ® Measures & Tips: Behavioral Health
Council of Governor’s Meeting
The early use of Antibiotics in at Risk CHildren with InfluEnza
Module 7 Communicating about CD-JEV vaccine with caregivers
Investing in good health at work
Flu vaccine What is flu? Benefits of the flu vaccine
What You Can Do to Help Prevent Antibiotic Resistance
Flu Vaccine Booking Guidance 20-Nov-18.
HOW TO ENTER BASELINE DATA
HOW TO SCREEN PATIENTS AND BOOK THE BASELINE VISIT APPOINTMENT?
CONDUCTING THE TRIAL AT
Recruitment Video Storyboard Template
MAINTAINING THE INVESTIGATOR’S STUDY FILE
WHAT TO DO IF A PATIENT DEVELOPS AN UNEXPECTED PROBLEM?
HELP KEEP ANTIBIOTICS WORKING
Site Initiation Meeting GP Practice
COMMUNITY PHARMACY WORKBOOK 2019 PUBLIC HEALTH DORSET
PPG Meeting on general practice is changing
Dinnington Group Practice Patient Newsletter
Let’s talk medicines safety
Flu vaccination in school 2017
Presentation transcript:

The early use of Antibiotics in at Risk CHildren with InfluEnza Chief Investigator: Dr Kay Wang Senior Trial Manager: Tricia Carver

Research questions Does early antibiotic use in ‘at risk’ children with influenza-like illness reduce the likelihood of re-consultation due to clinical deterioration? What impact might early antibiotic use have on antimicrobial resistance? Is early antibiotic use cost effective?

Recruitment plan 650 ‘at risk’ children with influenza-like illness Winters 2014/5 and 2015/6 (+/- 2016/7) – October to March – Bulk of recruitment during peak influenza season (December/January) Target: 8 recruits per site per season (2 per month)

You should have by now Completed the search and identified those at risk (the ‘golden ticket’ sent with the flu jab reminder) Set up the read code (if you code symptoms and signs for flu and flu like illness) Set up a IT flag if you wish Used the videos on the web to train all staff involved

Site training Videos on the ARCHIE web site Video 1 – eligibility assessment and recruitment tips Video 2 – baseline assessment consent and clinical details Video 3 – baseline assessment study medication and contact card Video 4 – questionnaires, diaries and arranging follow ups Video 5 – follow up assessment and adverse event reporting

Patients to consider for ARCHIE ‘At risk’ children aged 6 months to 12 years Cough AND fever (fever reported as symptom or temperature 37.9°C or higher during consultation) Within 5 days of symptom onset No known contraindication to co-amoxiclav Does not require immediate antibiotics or hospitalisation

Archie is more ill than usual when he just gets a cold or flu……… ……………… but I’m not sure if he is ill enough to need antibiotics.

Summary of study Day 1 Day 28 Day 7 Day 14 Enrolment and randomisation Day 21 3m +

Summary of study Day 1 Day 28 Day 7 Day 14 Enrolment and randomisation Day 21 3m +

Summary of study Day 1 Day 28 Day 7 Day 14 Return weekly diaries (parent ± child) Enrolment and randomisation Day 21 3m +

Summary of study Medical notes review (all children) Follow-up throat swabs (optional) Day 1 Day 28 Day 7 Day 14 Return weekly diaries (parent ± child) Enrolment and randomisation Day 21 3m +

Recruitment timeframe Same day if possible Following (working) day if still eligibility criteria – Complete eligibility assessment form on the same day as the baseline appointment

Face to face consultation Full eligibility assessment Baseline assessment Consider booking longer appointment or appointment at end of surgery Telephone consultation Initial eligibility assessment Introduce study (information leaflets on Study website Screen prompt Apply Read code for ‘At risk of influenza-related complications’

Recruitment tip 1 Ask parents and children to read the study information leaflets before the baseline appointment Patients can go to to: – Watch video clips about the study – Download study information leaflets – Read our Frequently Asked Questions

Baseline appointment (day 1) To be completed by healthcare professional – Eligibility assessment – Consent +/- assent – Baseline clinical assessment – Randomise and allocate study medication – Contact card To be completed by parent/guardian ± child – Contact information form – Questionnaires (two for parent, one for child) – Study diaries

Recruitment tip 2 Use the armpit thermometer provided to take the child’s temperature, and show the parent how to use it at the same time

Recruitment tip 3 While you prepare the child’s study medication, ask the parent and child to: – Complete the contact information form – Complete the study questionnaires – Look through the Diary – Instructions and Overview

Study medication Co-amoxiclav 400/57 or matching placebo Randomisation system accessible via website Key instructions for parents: – Keep medication refrigerated once reconstituted – Give first dose as soon as possible (consider during baseline appointment) – Can repeat dose if child vomits within 30 minutes of dose – Give child maximum of 10 doses – Discard leftover medication

Follow-up assessments Telephone follow-ups – Week 1 (day 7 to 10) – Week 2 (day 14 to 17) Objectives – Safety monitoring – Reminders to complete and return diaries – (Consent for additional throat swabs)

Follow-up throat swabs (optional) 3, 6 and 12 months (+/- 2 weeks) Study team will send swab extra swab kits and remind you to contact patient when swabs are due

Reimbursement Service support costs – Insert region specific details Research costs – Reimbursed annually by study team – £16.48 per child recruited into trial – £25.48 per child recruited into trial + follow-up throat swabs

Before you recruit.. Complete contract and send it to Oxford Complete delegation logs and send the access requirements to Oxford (for log-in details) Train all staff Receive ‘green light’ form from Oxford Then go …..

Thank you for listening Tel: Funded by NIHR Programme Grant for Applied Research RP-PG

FAQ- reconsultation Q: What is the procedure if a child reconsults because they are unwell while they are still taking their study medication? A: The clinician should assess and manage the child as they would based on their usual clinical practice. This may include issuing a prescription for antibiotics if the clinician considers that antibiotic treatment is indicated. The BNF states that the standard dose of co-amoxiclav can be doubled* when treating severe infections. The study medication dosing regimen in ARCHIE is based on the BNF standard dosing regimen. The child can therefore continue taking their study medication unless there is a reason to stop it (e.g. suspected allergic reaction). *caution advised in children with underlying conditions which may compromise the excretion or metabolism of co-amoxiclav, and in children weighting less than 6kg. In these children, an alternative antibiotic should be considered.